The Maldives Food and Drug Authority (MFDA) has said that there is no quality problem with the 500 mg of Panadol (Paracetamol) manufactured by a Sri Lankan company.

The MFDA said in an announcement today that Panadol 500 mg pills were found to have a quality problem, after which they had conducted lab tests of the medicine. The results of these tests have now been received.

Analysis reports confirm the strength of the medicine matches that of the "Panadol" brand (by quantitative test).

The problem occurred due to non-compliance with the standards for storage and transportation of the drug. The batch has now been withdrawn from the market, the MFDA said.

Therefore, the previously banned Panadol (Paracetamol) 500 mg oral medication is still allowed to be sold and used, the MFDA said.

The MFDA announcement added that the authority has issued standards for transportation and storage of drugs to prevent such problems from happening again.

For more information, the statement urged to contact the Medicines and Therapeutic Goods hotline numbers 7200321, 3014308 and 3014316.